Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Swanson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Advance for Nurse Practitioners|December 14, 2005
Financing your dreamMichael Swanson
Texas Heart Institute Journal|April 6, 2004
Pseudomonas mediastinitis at the aortic cannulation siteMichael Swanson
Texas Heart Institute Journal|May 21, 2005
Tricuspid repair and cavopulmonary anastomosis after blunt traumaMichael Swanson
Advance for Nurse Practitioners|February 14, 2006
Starting a med spaMichael Swanson
Statistical Methods in Medical Research|April 1, 2025
A Weibull mixture cure frailty model for high-dimensional covariatesFatih Kızılaslan, David Michael Swanson, Valeria Vitelli
Protein Expression and Purification|September 11, 2004
Purification of recombinant human carbonic anhydrase-II by metal affinity chromatography without incorporating histidine tagsAbir L Banerjee, Michael Swanson, Sanku Mallik, et al.
European Journal of Clinical Pharmacology|April 23, 2024
Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single‑dose, randomized, and double‑blind studyGaute Lyngstad, Per Skjelbred, David Michael Swanson, et al.
Journal of Pharmaceutical Sciences|February 5, 2022
Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment OutputsVibha Jawa, Jad Maamary, Michael Swanson, et al.
European Journal of Clinical Pharmacology|June 22, 2023
Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single-dose, randomized, and double-blind studyGaute Lyngstad, Per Skjelbred, David Michael Swanson, et al.
The AAPS Journal|August 26, 2022
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)Nazneen Bano, Christopher Ehlinger, Tong-Yuan Yang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Advance for Nurse Practitioners|December 14, 2005
Financing your dreamMichael Swanson
Texas Heart Institute Journal|April 6, 2004
Pseudomonas mediastinitis at the aortic cannulation siteMichael Swanson
Texas Heart Institute Journal|May 21, 2005
Tricuspid repair and cavopulmonary anastomosis after blunt traumaMichael Swanson
Advance for Nurse Practitioners|February 14, 2006
Starting a med spaMichael Swanson
Statistical Methods in Medical Research|April 1, 2025
A Weibull mixture cure frailty model for high-dimensional covariatesFatih Kızılaslan, David Michael Swanson, Valeria Vitelli
Protein Expression and Purification|September 11, 2004
Purification of recombinant human carbonic anhydrase-II by metal affinity chromatography without incorporating histidine tagsAbir L Banerjee, Michael Swanson, Sanku Mallik, et al.
European Journal of Clinical Pharmacology|April 23, 2024
Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single‑dose, randomized, and double‑blind studyGaute Lyngstad, Per Skjelbred, David Michael Swanson, et al.
Journal of Pharmaceutical Sciences|February 5, 2022
Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment OutputsVibha Jawa, Jad Maamary, Michael Swanson, et al.
European Journal of Clinical Pharmacology|June 22, 2023
Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single-dose, randomized, and double-blind studyGaute Lyngstad, Per Skjelbred, David Michael Swanson, et al.
The AAPS Journal|August 26, 2022
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)Nazneen Bano, Christopher Ehlinger, Tong-Yuan Yang, et al.
Pageof 3